Evidence map›Paper›PMID 42031881›Full record

ArticleScientific reports2026

LASSO-HHO two-stage hybrid gene selection framework for accurate Alzheimer's disease diagnosis.

Othman Asiry, Aliaa El-Gawady, Mohamed Meselhy Eltoukhy, Marwa F Mohamed

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Othman AsiryDepartment of Information Technology, College of Computing and Information Technology at Khulais, University of Jeddah, 23890, Jeddah, Saudi Arabia.
Aliaa El-GawadyDepartment of Information Systems, Faculty of Computers and Informatics, Suez Canal University, Ismailia, 41522, Egypt. alia_saad@ci.suez.edu.eg.
Mohamed Meselhy EltoukhyDepartment of Information Technology, College of Computing and Information Technology at Khulais, University of Jeddah, 23890, Jeddah, Saudi Arabia.
Marwa F MohamedDepartment of Computer Science, Faculty of Computers and Informatics, Suez Canal University, Ismailia, 41522, Egypt.

Funding

University of Jeddah UJ-23-AKSPE-14
6 · The paper itself

Abstract

Selecting informative genes is essential for building accurate and efficient diagnostic models, especially for high-dimensional gene expression data such as those related to Alzheimer's disease. These datasets typically involve thousands of genes with limited samples, increasing the risk of overfitting and computational complexity. To address this, we propose a LASSO-HHO Gene Selection (LHGS) framework. LASSO is first applied to reduce dimensionality by filtering irrelevant genes. A conditional HHO-based optimization stage is then applied only when the LASSO-selected subset does not achieve sufficient accuracy or remains relatively large. Otherwise, the LASSO-selected features are directly used without further optimization. Experimental results show that the proposed method reduces the number of selected genes by up to 99.9% while maintaining high performance. The experimental results indicate that 100% accuracy can be achieved on specific datasets. In particular, GSE48350 and GSE36980 achieved 100% accuracy using LASSO alone, whereas GSE118553 and GSE132903 required the full LHGS framework to achieve the same performance. The framework also improves computational efficiency within a consistent experimental setup by reducing the optimization search space after LASSO filtering. Overall, LHGS provides a practical and efficient solution for gene selection in high-dimensional biomedical data.

Indexed as

Alzheimer DiseaseComputational BiologyAlgorithmsDatabases, GeneticGene Expression ProfilingHumansAlzheimer’s diseaseClassificationEmbedded methodsGene expressionGene selectionWrapper methods

Identifiers

PMID42031881
PMCPMC13109393

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.